Is JetBlue a Good Airline Stock to Buy Now?

NASDAQ: JBLU | JetBlue Airways Corporation News, Ratings, and Charts

JBLU – Shares of JetBlue Airways (JBLU) have declined significantly over the past few months because of the setback tied to the omicron coronavirus variant and the Russian invasion of Ukraine. However, can it rebound by leveraging its services? Let’s find out.

Leading carrier JetBlue Airways Corporation (JBLU) provides air passenger transportation services. The company has been struggling to stay afloat due to omicron-related travel restrictions. It recently launched service between New York’s John F. Kennedy International Airport and Puerto Vallarta’s Gustavo Diaz Ordaz International Airport, expanding its service to the Mexican Pacific Coast. In addition, it exercised its option to add 30 additional Airbus A220-300 aircraft to its order book, to deliver more robust cost performance.

However, the stock has been hit hard by rising oil prices due to the U.S. ban on Russian oil imports. It has lost 19.8% over the past month to close yesterday’s trading session at $12.74. In addition, it is currently trading 42% below its 52-week high of $21.96, which it hit on April 6, 2021. Also, analysts expect its EPS to decline at a rate of 126.4% per annum over the next five years. So, JBLU’s near-term prospects look uncertain.

Here’s what could influence JBLU’s performance in the upcoming months:

Lower-Than-Industry Valuation

In terms of forward P/S, JBLU’s 0.47x is 66.4% lower than the industry average of 1.40x. Likewise, its forward EV/S of 0.70x is 60.2% lower than the industry average of 1.76x. Moreover, the stock’s forward P/B and EV/EBITDA of 1.07x and 7.66x are higher than the industry averages of 2.57x and 11.24x, respectively.

Top Line Growth Doesn’t Translate into Bottom Line Improvement

For the fiscal fourth quarter ended December 31, 2021, JBLU’s revenue surged 177.3% year-over-year to $1.83 billion. However, its operating loss for the quarter came in at $119 million compared to $454 million in the previous year’s quarter. In comparison, its net loss came in at $129 million, compared to $373 million in the prior-year period. Its loss per share came in at $0.40, compared to $1.31 in the year-ago period.

Low Profitability

In terms of trailing-12-month gross profit margin, JBLU’s 14.74% is 49.5% lower than the industry average of 29.19%. Likewise, its trailing-12-month asset turnover ratio of 0.45% is 42.8% lower than the industry average of 0.78%. Moreover, the stock’s trailing-12-month ROCE, ROTC, and ROTA are negative compared to the industry averages of 13.68%, 6.85%, and 5.16%, respectively.

POWR Ratings Don’t Indicate Enough Upside

JBLU has an overall rating of C, which equates to a Neutral in our POWR Ratings system. The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight different categories. JBLU has a C grade for Quality, in sync with its lower-than-industry profitability ratios.

The stock has a D grade for Momentum, consistent with its 30.9% loss over the past nine months and 36% decline over the past year. In addition, JBLU has a D grade for Stability, consistent with its beta of 1.39.

JBLU also has a C grade for Growth and Sentiment. This is justified as analysts expect its EPS to remain negative in the current quarter and year.

JBLU is ranked #14 out of 31 stocks in the F-rated Airlines industry. Click here to access all of JBLU’s ratings.

Bottom Line

JBLU is currently trading below its 50-day and 200-day moving averages of $14.58 and $15.37, respectively, indicating a downtrend. Moreover, it could keep losing in the near term due to service disruptions caused by omicron and high crude oil prices. So, it could be wise to wait for a better entry point in the stock.

How Does JetBlue Airways (JBLU) Stack Up Against its Peers?

JBLU has an overall POWR Rating of C, equating to a Neutral rating. There are no stocks in the Airlines industry with an A (Strong Buy) or B (Buy) rating. The other three industry participants, Air France-KLM SA (AFLYY), Qantas Airways Limited (QABSY), and SkyWest, Inc. (SKYW), are also rated C.

JBLU shares were trading at $12.70 per share on Friday afternoon, down $0.04 (-0.31%). Year-to-date, JBLU has declined -10.81%, versus a -10.80% rise in the benchmark S&P 500 index during the same period.

About the Author: Nimesh Jaiswal

Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
JBLUGet RatingGet RatingGet Rating
AFLYYGet RatingGet RatingGet Rating
QABSYGet RatingGet RatingGet Rating
SKYWGet RatingGet RatingGet Rating

Most Popular Stories on

3 Safe Gold Stocks Pointing to Buy

Gold is often considered a safe-haven asset during economic uncertainty and is used as a hedge against inflation. Given a long-term robust outlook for gold on solid demand and rising prices, fundamentally sound gold stocks Alamos (AGI), Harmony Gold Mining (HMY), and Eldorado Gold (EGO) could be solid buys for steady returns. Keep reading…

Why the Bull Market is Still in Charge?

It’s been nearly 2 months that the S&P 500 (SPY) has been mired in a trading range. That is why investment veteran Steve Reitmeister shares his latest insights to explain why a bull market is still in place...and how to target the best stocks and ETFs for the days ahead. Read on for the full story below...

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits. Novo Nordisk (NVO), Regeneron (REGN) and Corcept Therapeutics (CORT) are deserving of a very close look right now.

Coca-Cola (KO) and 2 More Beverage Stocks – Buy or Sell?

The beverage industry exhibits a bright outlook due to evolving consumer preferences amid rising health consciousness. Therefore, let us analyze whether leading beverage stocks Coca-Cola (KO), National Beverage (FIZZ), and Celsius Holdings (CELH) are Buy, Hold, or Sell now. Read more...

The ODD Story Behind Thursday’s BIG Stock Rally

We have all been worried about what high inflation will do to the economy and stock market. And yet on Thursday inflation spiked again, yet amazingly the S&P 500 (SPY) had a great session. Investment veteran Steve Reitmeister shares the reasons why in his new market outlook with trading plan and top picks. Read on below for more...

Read More Stories

More JetBlue Airways Corporation (JBLU) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JBLU News